Male Urogenital Diseases

160 trials 69 recruiting

Filter these 160 trials by phase, country and sponsor.

Open in Search →

CYPENZA - A prospective cohort trial on antiandrogens influences on the pharmacokinetics of corticosteroids. Pending

2025-520571-66-00 Prostate cancer 5
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to the Renal Pelvis (LUNAR) Pending

2024-514360-70-00 Low-grade upper track urothelial carcinoma (LG-UTUC) 9
Personalized antibiotic TREATment for febrile Urinary Tract Infections in children (TREAT-UTI study): multicenter randomized controlled tria… Pending

2025-520622-38-00 Urinary Tract Infections 5
A trial to learn how safe AZD9750 is and how well it works in people with metastatic prostate cancer when given with or without other antica… Pending

2024-516976-14-00 Metastatic Prostate Cancer 7
Molecular theranostics for metastatic prostate cancer: PSMA, FAPI, or both? Pending

2024-511104-16-00 Prostate cancer 4
DUAL Pending

2023-505453-40-00 Prostate cancer 7
Diagnosing Vesicoureteric Reflux in Children by Direct Isotope Cystography and Contrast Enhanced Voiding Ultrasonography Pending

2024-518974-15-01 Vesicoureteral reflux 6
The GranStone Trial Pending

2026-525608-85-00 Paraffin Oil Induced Granulomatous Disease 10
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease Recruiting

2025-521752-26-00 Complement-Mediated Kidney Disease 4 2026-04-22
A phase II, double-blind, randomised, placebo-controlled trial to evaluate the efficacy and tolerability of a rectal treatment with budesoni… Recruiting

2024-519359-27-00 Acute radiation proctitis symptoms in male patients age 4 2026-04-16
A study to find out if BI 764198 helps adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS) Recruiting

2025-522191-86-00 Focal segmental glomerulosclerosis 5 2026-04-02
Daridorexant treatment in adolescents with enuresis. Recruiting

2025-521443-20-00 Nocturnal enuresis 5 2026-03-11
A study comparing nadofaragene firadenovec with standard of care in adults with an increased risk that non-muscle invasive bladder cancer ma… Recruiting

2024-512029-10-00 Intermediate risk, non-muscle invasive bladder cancer 5 2025-12-05
A study to test if difelikefalin is safe in adolescents with itching related to long term kidney disease Recruiting

2023-509909-74-00 Pruritus 4 2025-08-13
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN). Recruiting

2024-514135-17-00 Immunoglobulin A Nephropathy 5 2024-11-28
A Phase I, open-label study in healthy adults comparing the availability in the body of the active substance lidocaine following administrat… Recruiting

2026-525752-29-00 bioavailability trial with healthy participants, therap 2 2026-06-01
Pilot Study to Evaluate Safety and Efficacy of PolyCore, a Ternary Combination of Xylitol, L-Carnitine and Polydextrin, to Treat End-Stage K… Recruiting

2024-519366-52-00 End-Stage Kidney Disease 4 2026-02-17
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer with Disease Progression on or Af… Recruiting

2025-522400-24-00 Metastatic urothelial cancer 10 2026-01-27
PULSE : Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including a platinum salt in patie… Recruiting

2024-514997-27-00 cell penile carcinoma 4 2025-12-18
A study to evaluate the impact on metastases-free survival with the addition of saruparib vs placebo to a standard radiotherapy androgen dep… Recruiting

2024-513586-39-00 Prostate Cancer 5 2025-12-10
DEPECA-1 – DEfeating PEnile CAncer 1 – A Phase II study to evaluate a first-line systemic therapy with enfortumab vedotin plus avelumab for … Recruiting

2025-521644-37-00 locally advanced or metastatic penile squamous cell car 4 2025-11-28
A First-In-Human, phase I/IIa, open-label trial assessing safety, tolerability, and feasibility of repeated administrations of a novel autol… Recruiting

2025-521227-70-00 Patients with locally advanced or metastatic prostate c 7 2025-11-13
A study to learn about nadofaragene firadenovec given alone or together with gemcitabine and docetaxel or, pembrolizumab in adults with non-… Recruiting

2024-512177-27-01 High-risk Bacillus Calmette-Guerin (BCG)-unresponsive n 5 2025-09-29
CLEARTOX: Development of an innovative haemodialysis method to improve dialytic clearance of protein-bound uraemic toxins Recruiting

2023-510406-41-00 chronic hemodialysis patients (for more than 3 months) 4 2025-09-22